SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-19-014679
Filing Date
2019-08-06
Accepted
2019-08-06 13:29:13
Documents
1
Period of Report
2019-08-29
Effectiveness Date
2019-08-06

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a0819_oramedpharma.htm DEF 14A 544134
  Complete submission text file 0001213900-19-014679.txt   545396
Mailing Address 1185 AVENUE OF THE AMERICAS, SUITE 228 NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, SUITE 228 NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: DEF 14A | Act: 34 | File No.: 001-35813 | Film No.: 191001326
SIC: 2834 Pharmaceutical Preparations